Stock on Demand This Week: Morgan Stanley (MS)

0
10

Morgan Stanley (NYSE:MS) saw an upside of 0.92% to close Monday at $97.13 after adding $0.89 on the day. The 5-day average trading volume is 15,005,239 shares of the company’s common stock. It has gained $99.10 in the past week and touched a new high 1 time within the past 5 days. An average of 7,928,455 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 7,320,146.

MS’s 1-month performance is 14.06% or $11.02 on its low of $84.06 reached on 12/28/22. The company’s shares have touched a 52-week low of $72.05 and high of $109.73, with the stock’s rally to the 52-week high happening on 01/17/23. YTD, MS has achieved 14.24% or $12.11 and has reached a new high 9 times. However, the current price is down -11.48% from the 52-week high price.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Insider Transactions

MS stock investors last saw insider trading activity on Jan 19.CRAWLEY MANDELL (Chief Human Resources Officer) most recently sold 3,740 shares at $93.75 per share on Jan 19. This transaction cost the insider $350,625. Deputy Chief Financial Officer, AKRAM RAJA, sold 5,100 shares at a price of $97.00 on Jan 18. Then, on Jan 18, Head of Investment Management SIMKOWITZ DANIEL A sold 44,910 shares at a price of $97.05 per share. This transaction amounted to $4,358,353.

Valuation Metrics

MS stock has a beta of 1.33. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 2.41 while the price-to-book (PB) in the most recent quarter is 1.76, with the price to cash flow ratio at 15.80.

As well, the company’s long term debt to equity for the quarter ending September 29 was 2.35, while the total debt to equity was 6.85. In terms of profitability, the gross margin trailing 12 months is 76.10%. The firm’s gross profit as reported stood at $19.67 billion against revenue of $59.76 billion.

Earnings Surprise

For the quarterly period ending September 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected MS to announce $29.4 per share in earnings in its latest quarter, but it posted $29.32, representing a -0.30% surprise. EBITDA for the quarter stood at more than $4.32 billion. Shareholders hold equity totaling $1.69 billion.

Let’s look briefly at Morgan Stanley (MS) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 23 January was 73.32% to suggest the stock is trending Overbought, with historical volatility in this time period at 31.76%.

The stock’s 5-day moving average is $96.24, reflecting a +5.97% or $5.47 change from its current price. MS is currently trading +11.81% above its 20-day SMA, +13.80% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +13.90% and SMA200 by+13.90%.

Stochastic %K and %D was 77.96% and 77.94% and the average true range (ATR) pointed at 2.53. The RSI (14) points at 69.16%, while the 14-day stochastic is at 86.19% with the period’s ATR at 2.40. The stock’s 9-day MACD Oscillator is pointing at 2.32 and 4.75 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Morgan Stanley (NYSE: MS), Citigroup downgraded it to a Neutral rating. They previously had a Buy rating on the stock. Analysts offering their rating for MS stock have a consensus rating for the stock as Overweight. Currently, 1 brokerage advisors rate MS as a “sell,”, while 11 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 14 have offered a “buy” rating.

LEAVE A REPLY

Please enter your comment!
Please enter your name here